Used in pharmaceutical research as a key intermediate in the synthesis of sigma receptor ligands, particularly targeting the sigma-1 receptor subtype. It has shown potential in the development of treatments for neurological disorders such as Alzheimer's disease, neuropathic pain, and depression due to its ability to modulate cellular signaling pathways involved in neuroprotection and neurotransmission. Its adamantane-derived structure enhances blood-brain barrier penetration, making it valuable in central nervous system drug design. Also explored in oncology for its role in sensitizing cancer cells to chemotherapeutic agents through modulation of endoplasmic reticulum stress responses.